BANSAL AJAY 4
4 · Urovant Sciences Ltd. · Filed Nov 5, 2019
Insider Transaction Report
Form 4
BANSAL AJAY
PFO;CFO/Urovant Sciences, Inc.
Transactions
- Award
Common Shares
2019-11-05+75,000→ 75,000 total - Award
Stock Option (Right to Buy)
2019-11-05+140,000→ 140,000 totalExercise: $9.66Exp: 2029-11-05→ Common Shares (140,000 underlying)
Footnotes (2)
- [F1]25% of the Restricted Stock Units shall vest on October 28, 2020; the remaining Restricted Stock Units vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date.
- [F2]25% of the total shares underlying the option shall vest and become exercisable on October 28, 2020; the remaining shares vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date.